Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Holly B. Kordasiewicz currently holds 22,096 shares of IONIS PHARMACEUTICALS INC (IONS), valued at approximately $0. This represents their equity stake as EVP, Chief Development Officer.
Based on SEC Form 4 filings, Holly B. Kordasiewicz has been a net seller of IONS stock. They have purchased $0 and sold $30.5K worth of shares.
Holly B. Kordasiewicz's most recent insider trade was on Jul 7, 2026, when they sold 362 shares at $84.30 per share.
Holly B. Kordasiewicz serves as EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC (IONS). They have executed 2 insider transactions totaling $30.5K over their tenure at the company.
Holly B. Kordasiewicz holds the position of EVP, Chief Development Officer at IONIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Holly B. Kordasiewicz has shown a selling trading pattern, with $0 in total purchases and $30.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Holly B. Kordasiewicz was on Jul 7, 2026, when they sold $30.5K worth of IONS shares. This transaction involved 362 shares at $84.30 per share.
Holly B. Kordasiewicz currently owns 22,096 shares of IONIS PHARMACEUTICALS INC (IONS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Holly B. Kordasiewicz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Holly B. Kordasiewicz has 2 Form 4 filings on record as an insider at IONIS PHARMACEUTICALS INC.
Set alerts for Holly B. Kordasiewicz and 40,000+ other insiders.